Annual Long Term Debt
$271.60 K
-$14.65 M-98.18%
31 December 2023
Summary:
Aldeyra Therapeutics annual long term debt is currently $271.60 thousand, with the most recent change of -$14.65 million (-98.18%) on 31 December 2023. During the last 3 years, it has fallen by -$11.16 million (-97.62%). ALDX annual long term debt is now -98.26% below its all-time high of $15.63 million, reached on 31 December 2021.ALDX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$15.07 M
+$14.93 M+10749.68%
30 September 2024
Summary:
Aldeyra Therapeutics quarterly long term debt is currently $15.07 million, with the most recent change of +$14.93 million (+10749.68%) on 30 September 2024. Over the past year, it has increased by +$12.41 million (+467.15%). ALDX quarterly long term debt is now -3.70% below its all-time high of $15.65 million, reached on 31 March 2022.ALDX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALDX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -98.2% | +467.1% |
| 3 y3 years | -97.6% | -3.4% |
| 5 y5 years | - | +4.3% |
ALDX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -98.3% | at low | -3.7% | >+9999.0% |
| 5 y | 5 years | -98.3% | at low | -3.7% | >+9999.0% |
| alltime | all time | -98.3% | +2.0% | -3.7% | >+9999.0% |
Aldeyra Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $15.07 M(>+9900.0%) |
| June 2024 | - | $138.90 K(-32.6%) |
| Mar 2024 | - | $206.00 K(-24.2%) |
| Dec 2023 | $271.60 K(-98.2%) | $271.60 K(-89.8%) |
| Sept 2023 | - | $2.66 M(-73.8%) |
| June 2023 | - | $10.13 M(-32.3%) |
| Mar 2023 | - | $14.97 M(+0.3%) |
| Dec 2022 | $14.92 M(-4.5%) | $14.92 M(+351.8%) |
| Sept 2022 | - | $3.30 M(-69.3%) |
| June 2022 | - | $10.74 M(-31.4%) |
| Mar 2022 | - | $15.65 M(+0.1%) |
| Dec 2021 | $15.63 M(+36.7%) | $15.63 M(+0.1%) |
| Sept 2021 | - | $15.61 M(+1.7%) |
| June 2021 | - | $15.34 M(+51.3%) |
| Mar 2021 | - | $10.14 M(-11.3%) |
| Dec 2020 | $11.43 M(-21.3%) | $11.43 M(-9.9%) |
| Sept 2020 | - | $12.69 M(-8.8%) |
| June 2020 | - | $13.92 M(-5.1%) |
| Mar 2020 | - | $14.67 M(+1.0%) |
| Dec 2019 | $14.53 M | $14.53 M(+0.6%) |
| Sept 2019 | - | $14.45 M(>+9900.0%) |
| June 2019 | - | $116.10 K(-26.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $156.80 K(-82.2%) |
| Sept 2018 | - | $882.80 K(-11.3%) |
| June 2018 | - | $995.30 K(-10.1%) |
| Mar 2018 | - | $1.11 M(-9.2%) |
| Dec 2017 | $1.22 M(-1.5%) | $1.22 M(+34.8%) |
| Sept 2017 | - | $905.30 K(-10.9%) |
| June 2017 | - | $1.02 M(-9.9%) |
| Mar 2017 | - | $1.13 M(-9.0%) |
| Dec 2016 | $1.24 M(+2.3%) | $1.24 M(+40.2%) |
| Sept 2016 | - | $883.30 K(-11.0%) |
| June 2016 | - | $992.60 K(-9.9%) |
| Mar 2016 | - | $1.10 M(-9.0%) |
| Dec 2015 | $1.21 M(+3.0%) | $1.21 M(-5.4%) |
| Sept 2015 | - | $1.28 M(+33.2%) |
| June 2015 | - | $961.50 K(-10.0%) |
| Mar 2015 | - | $1.07 M(-9.1%) |
| Dec 2014 | $1.18 M(+4.1%) | $1.18 M(-5.3%) |
| Sept 2014 | - | $1.24 M(+52.1%) |
| June 2014 | - | $815.80 K(-16.1%) |
| Mar 2014 | - | $972.40 K(-13.9%) |
| Dec 2013 | $1.13 M(+324.0%) | $1.13 M(+221.8%) |
| Sept 2013 | - | $350.80 K(+31.7%) |
| Dec 2012 | $266.30 K | $266.30 K |
FAQ
- What is Aldeyra Therapeutics annual long term debt?
- What is the all time high annual long term debt for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual long term debt year-on-year change?
- What is Aldeyra Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly long term debt year-on-year change?
What is Aldeyra Therapeutics annual long term debt?
The current annual long term debt of ALDX is $271.60 K
What is the all time high annual long term debt for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual long term debt is $15.63 M
What is Aldeyra Therapeutics annual long term debt year-on-year change?
Over the past year, ALDX annual long term debt has changed by -$14.65 M (-98.18%)
What is Aldeyra Therapeutics quarterly long term debt?
The current quarterly long term debt of ALDX is $15.07 M
What is the all time high quarterly long term debt for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly long term debt is $15.65 M
What is Aldeyra Therapeutics quarterly long term debt year-on-year change?
Over the past year, ALDX quarterly long term debt has changed by +$12.41 M (+467.15%)